Celcuity Inc (CELC)
14.13
-0.50
(-3.42%)
USD |
NASDAQ |
Nov 14, 16:00
14.13
0.00 (0.00%)
After-Hours: 20:00
Celcuity Enterprise Value: 354.88M for Nov. 13, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2024 | 354.88M |
| November 12, 2024 | 366.36M |
| November 11, 2024 | 394.50M |
| November 08, 2024 | 400.05M |
| November 07, 2024 | 395.61M |
| November 06, 2024 | 414.87M |
| November 05, 2024 | 377.10M |
| November 04, 2024 | 381.91M |
| November 01, 2024 | 365.99M |
| October 31, 2024 | 387.09M |
| October 30, 2024 | 400.42M |
| October 29, 2024 | 402.28M |
| October 28, 2024 | 395.98M |
| October 25, 2024 | 391.17M |
| October 24, 2024 | 398.20M |
| October 23, 2024 | 398.94M |
| October 22, 2024 | 418.57M |
| October 21, 2024 | 410.42M |
| October 18, 2024 | 399.31M |
| October 17, 2024 | 385.24M |
| October 16, 2024 | 401.91M |
| October 15, 2024 | 397.09M |
| October 14, 2024 | 374.50M |
| October 11, 2024 | 374.50M |
| October 10, 2024 | 350.06M |
| Date | Value |
|---|---|
| October 09, 2024 | 345.25M |
| October 08, 2024 | 378.21M |
| October 07, 2024 | 378.58M |
| October 04, 2024 | 370.06M |
| October 03, 2024 | 361.91M |
| October 02, 2024 | 356.36M |
| October 01, 2024 | 353.03M |
| September 30, 2024 | 365.25M |
| September 27, 2024 | 346.36M |
| September 26, 2024 | 340.44M |
| September 25, 2024 | 344.51M |
| September 24, 2024 | 341.92M |
| September 23, 2024 | 330.81M |
| September 20, 2024 | 363.02M |
| September 19, 2024 | 375.61M |
| September 18, 2024 | 368.95M |
| September 17, 2024 | 367.84M |
| September 16, 2024 | 373.76M |
| September 13, 2024 | 367.84M |
| September 12, 2024 | 355.62M |
| September 11, 2024 | 388.57M |
| September 10, 2024 | 403.02M |
| September 09, 2024 | 377.10M |
| September 06, 2024 | 370.80M |
| September 05, 2024 | 394.13M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
16.44M
Minimum
May 13 2022
521.96M
Maximum
Jul 25 2024
166.60M
Average
110.42M
Median
Aug 09 2023
Enterprise Value Benchmarks
| CEL-SCI Corp | 38.36M |
| AIM ImmunoTech Inc | 7.900M |
| IGC Pharma Inc | 26.09M |
| NovaBay Pharmaceuticals Inc | 2.762M |
| Protalix BioTherapeutics Inc | 66.58M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -23.72M |
| Total Expenses (Quarterly) | 24.28M |
| EPS Diluted (Quarterly) | -0.62 |
| Earnings Yield | -19.32% |